IceCure Medical
ICCM | NASDAQ
$0.76
+$0.03 (+4.11%)
At close: Nov 16, 2026, 4:00 PM ET
$0.80
+$0.04 (+5.26%)
After-hours:
Nov 16, 2026, 7:43 PM ET
+4.11%
(1D)No price chart data available for 1D timeframe.
Rating
48
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #322/1021 (Top 32%)
Key Statistics
Market Data
Market Cap $2.35M
1D Range
0.74 0.80
52W Range
0.68 21.90
Valuation (TTM)
PE -0.11
PB 0.20
EV/EBITDA 0.58
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target $1.00
Cash Flow
FCF Yield -698.6%
SBC Adj. FCF Yield -738.2%
SBC Impact -5.7%
Margins
Gross Margin 36.1%
Operating Margin -556.4%
FCF Margin -415.2%
Growth (CAGR)
Revenue 3Y | 5Y 7.0% |
-0.7%
Dil EPS 3Y | 5Y 13.1% |
16.2%
FCF 3Y | 5Y -18.4% |
0.7%
Returns
ROA -95.3%
ROE -174.3%
ROIC -183.2%
Financial Health
Net Cash
$12.03M
Current Ratio 2.87
Interest Coverage -139.87
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumor...
Sector Healthcare
Industry Medical - Devices
Employees 68
IPO Date Aug 26, 2021
Website www.icecure-medical.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$1.00
Upside
+31.58%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove ICCM